GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » CH Biotech R&D Co Ltd (TPE:6534) » Definitions » Retained Earnings

CH Biotech R&D Co (TPE:6534) Retained Earnings : NT$557 Mil (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is CH Biotech R&D Co Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. CH Biotech R&D Co's retained earnings for the quarter that ended in Dec. 2024 was NT$557 Mil.

CH Biotech R&D Co's quarterly retained earnings declined from Jun. 2024 (NT$737 Mil) to Sep. 2024 (NT$539 Mil) but then increased from Sep. 2024 (NT$539 Mil) to Dec. 2024 (NT$557 Mil).

CH Biotech R&D Co's annual retained earnings declined from Dec. 2022 (NT$587 Mil) to Dec. 2023 (NT$494 Mil) but then increased from Dec. 2023 (NT$494 Mil) to Dec. 2024 (NT$557 Mil).


CH Biotech R&D Co Retained Earnings Historical Data

The historical data trend for CH Biotech R&D Co's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CH Biotech R&D Co Retained Earnings Chart

CH Biotech R&D Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 181.05 410.30 587.35 493.87 556.97

CH Biotech R&D Co Quarterly Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 493.87 595.29 737.46 539.18 556.97

CH Biotech R&D Co Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


CH Biotech R&D Co  (TPE:6534) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


CH Biotech R&D Co Business Description

Traded in Other Exchanges
N/A
Address
No. 89, Wenxian Road, Nantou, TWN, 54041
CH Biotech R&D Co Ltd is a Taiwan-based company engaged in the manufacture and sales of fertilizer, as well as providing biotechnology services. It is engaged in the research, development, manufacturing, & sales of proprietary plant growth regulators & specialty micronutrient fertilizers. Its products include nutrient Efficiency Stress Reduction, Plant Growth Promotion, Crop Fruit Quality, Plant Derived Biotechnology. Geographically it generates the majority of its revenue from the United States.

CH Biotech R&D Co Headlines

No Headlines